Evidence map›Paper›PMID 16728755›Full record

ArticleTobacco control2006

Fiscal versus social responsibility: how Philip Morris shaped the public funds divestment debate.

N Wander, R E Malone

Abstract read
In one paragraph

Article in Tobacco control, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Corporate philanthropy, lobbying, and public health policy.American journal of public health · 2008
    Review
  5. Making big tobacco give in: you lose, they win.American journal of public health · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

N WanderDepartment of Social & Behavioral Sciences and Center for Tobacco Control Research and Education, University of California, San Francisco 94143-0612, USA. nathaniel.wander@ucsf.edu
R E Malone

Funding

Responses to Public Health CampaignsR01CA095989 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALONE, RUTH E · 2003 to 2006
$857k
NCI NIH HHS CA095989NCI NIH HHS R01 CA095989
6 · The paper itself

Abstract

Calls for institutional investors to divest (sell off) tobacco stocks threaten the industry's share values, publicise its bad behaviour, and label it as a politically unacceptable ally. US tobacco control advocates began urging government investment and pension funds to divest as a matter of responsible social policy in 1990. Following the initiation of Medicaid recovery lawsuits in 1994, advocates highlighted the contradictions between state justice departments suing the industry, and state health departments expanding tobacco control programmes, while state treasurers invested in tobacco companies. Philip Morris (PM), the most exposed US company, led the divestment opposition, consistently framing the issue as one of responsible fiscal policy. It insisted that funds had to be managed for the exclusive interest of beneficiaries, not the public at large, and for high share returns above all. This paper uses tobacco industry documents to show how PM sought to frame both the rhetorical contents and the legal contexts of the divestment debate. While tobacco stock divestment was eventually limited to only seven (but highly visible) states, US advocates focused public attention on the issue in at least 18 others plus various local jurisdictions. This added to ongoing, effective campaigns to denormalise and delegitimise the tobacco industry, dividing it from key allies. Divestment as a delegitimisation tool could have both advantages and disadvantages as a tobacco control strategy in other countries.

Indexed as

Conflict of InterestSocial ResponsibilityFinancial ManagementGovernmentHumansInvestmentsPersuasive CommunicationTobacco IndustryUnited StatesUniversities

Identifiers

PMID16728755
PMCPMC2596576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.